Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuropeptides in anxiety modulation.

R Landgraf1

  • 1Max Planck Institute of Psychiatry, Kraepelinstr. 2-10, 80804 Munich, Germany. landgraf@mpipsykl.mpg.de

Handbook of Experimental Pharmacology
|April 6, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enriched environment impacts trimethylthiazoline-induced anxiety-related behavior and immediate early gene expression: critical role of Crhr1.

The European journal of neuroscience·2014
Same author

Bidirectional rescue of extreme genetic predispositions to anxiety: impact of CRH receptor 1 as epigenetic plasticity gene in the amygdala.

Translational psychiatry·2014
Same author

Oxytocin in Brattleboro rats: increased synthesis is contrasted by blunted intrahypothalamic release from supraoptic nucleus neurones.

Journal of neuroendocrinology·2013
Same author

Plasma oxytocin and vasopressin do not predict neuropeptide concentrations in human cerebrospinal fluid.

Journal of neuroendocrinology·2013
Same author

Anxiety- rather than depression-like behavior is associated with adult neurogenesis in a female mouse model of higher trait anxiety- and comorbid depression-like behavior.

Translational psychiatry·2012
Same author

Truncated p110 ERBB2 induces mammary epithelial cell migration, invasion and orthotopic xenograft formation, and is associated with loss of phosphorylated STAT5.

Oncogene·2012

Neuropeptides significantly influence anxiety behaviors. Research highlights corticotropin-releasing hormone (CRH) and vasopressin (AVP) as key regulators, offering potential for new anxiety treatments.

Area of Science:

  • Neuroscience
  • Behavioral Science
  • Pharmacology

Background:

  • Neuropeptides are crucial endogenous modulators of complex behaviors, including anxiety and psychopathology.
  • Their diverse nature, varied release patterns, and complex communication modes underscore their significant role in brain function.
  • Understanding neuropeptide involvement is key to deciphering anxiety-related behavior and associated disorders.

Purpose of the Study:

  • To review the role of neuropeptides in modulating physiological and pathological anxiety.
  • To focus on neuropeptides with established anxiolytic or anxiogenic effects.
  • To explore the potential of neuropeptidergic systems as targets for novel anxiolytic strategies.

Main Methods:

  • Review of existing literature on neuropeptide involvement in anxiety.

Related Experiment Videos

  • Analysis of loss-of-function and gain-of-function studies on central neuropeptidergic systems.
  • Concentration on neuropeptides with well-established roles, particularly corticotropin-releasing hormone (CRH) and vasopressin (AVP).

    • Main Results:

    • Neuropeptides are integral to the modulation of anxiety-related behaviors and psychopathology.
    • Corticotropin-releasing hormone (CRH) and vasopressin (AVP) are critically involved in regulating anxiety in rodents, linked to stress, neuroendocrine function, and social behavior.
    • Complementary experimental approaches confirm the anxiolytic or anxiogenic roles of specific neuropeptides.

    Conclusions:

    • Neuropeptidergic systems are vital regulators of anxiety.
    • CRH and AVP are key players in anxiety-related behaviors, with implications for stress and social interactions.
    • Further characterization of these systems may lead to the development of effective anxiolytic therapies.